HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro.
about
Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients.ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer.A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis.Promising clinical application of ctDNA in evaluating immunotherapy efficacy
P2860
HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@ast
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@en
type
label
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@ast
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@en
prefLabel
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@ast
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@en
P2093
P2860
P1476
HER2-specific T lymphocytes ki ...... ve breast cell lines in vitro.
@en
P2093
Feng-Ling Wan
Xiao-Li Wang
Xiao-Lin Lin
Yan-Hua Yuan
P2860
P2888
P304
P356
10.1007/S11670-012-0143-6
P577
2012-06-01T00:00:00Z